1
/
of
1
Elabscience
SKU:PKSH032108
Recombinant Human BPI/CAP57 Protein (His Tag)
Recombinant Human BPI/CAP57 Protein (His Tag)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human BPI/CAP57 Protein (His Tag), a cutting-edge product meticulously engineered to meet the highest standards of quality and efficacy. This protein, derived from advanced recombinant technology, showcases a His Tag for enhanced purification and detection capabilities.
The Recombinant Human BPI/CAP57 Protein (His Tag) is a paramount tool in various research applications, particularly in the fields of immunology, microbiology, and infectious diseases. With its exceptional purity and stability, this protein offers unparalleled reliability and reproducibility, ensuring accurate and consistent results.
Crafted with utmost precision, this product exhibits remarkable biological activity, making it an invaluable asset in elucidating the intricate mechanisms underlying host defense and immune response. Its unique composition enables comprehensive investigations into the interactions between the human body and pathogens, shedding light on the development of novel therapeutic strategies.
Furthermore, the inclusion of the His Tag in the Recombinant Human BPI/CAP57 Protein facilitates effortless purification, simplifying experimental workflows and saving valuable time and resources. This feature also enables seamless detection and quantification, empowering researchers to delve deeper into the protein's functions and interactions.
Rest assured, the Recombinant Human BPI/CAP57 Protein (His Tag) adheres to stringent quality control measures, ensuring batch-to-batch consistency and utmost reliability. Each vial is meticulously packaged to maintain the protein's integrity and activity, guaranteeing optimal performance throughout its shelf life.
In summary, the Recombinant Human BPI/CAP57 Protein (His Tag) stands as a pinnacle of scientific innovation, offering researchers an indispensable tool to unravel the complexities of host-pathogen interactions. With its exceptional purity, stability, and ease of use, this protein is poised to revolutionize the field of immunology and pave the way for groundbreaking discoveries.
The Recombinant Human BPI/CAP57 Protein (His Tag) is a paramount tool in various research applications, particularly in the fields of immunology, microbiology, and infectious diseases. With its exceptional purity and stability, this protein offers unparalleled reliability and reproducibility, ensuring accurate and consistent results.
Crafted with utmost precision, this product exhibits remarkable biological activity, making it an invaluable asset in elucidating the intricate mechanisms underlying host defense and immune response. Its unique composition enables comprehensive investigations into the interactions between the human body and pathogens, shedding light on the development of novel therapeutic strategies.
Furthermore, the inclusion of the His Tag in the Recombinant Human BPI/CAP57 Protein facilitates effortless purification, simplifying experimental workflows and saving valuable time and resources. This feature also enables seamless detection and quantification, empowering researchers to delve deeper into the protein's functions and interactions.
Rest assured, the Recombinant Human BPI/CAP57 Protein (His Tag) adheres to stringent quality control measures, ensuring batch-to-batch consistency and utmost reliability. Each vial is meticulously packaged to maintain the protein's integrity and activity, guaranteeing optimal performance throughout its shelf life.
In summary, the Recombinant Human BPI/CAP57 Protein (His Tag) stands as a pinnacle of scientific innovation, offering researchers an indispensable tool to unravel the complexities of host-pathogen interactions. With its exceptional purity, stability, and ease of use, this protein is poised to revolutionize the field of immunology and pave the way for groundbreaking discoveries.
Share
